Showing results (41-50 of 195) with videos related to
Sort By:
Pageof 20
Leukemia Research|May 6, 2021
A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemiaPankit Vachhani, Jeffrey Baron, Craig W Freyer, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 22, 2022
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplantRachel V Hatch, Craig W Freyer, Alison Carulli, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2018
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant RecipientsAlex Ganetsky, Jennifer H Han, Mitchell E Hughes, et al.Leukemia & Lymphoma|June 3, 2020
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementationCraig W Freyer, Alison Carulli, Alex Ganetsky, et al.Leukemia & Lymphoma|March 8, 2022
Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemiaMolly E Graveno, Alison Carulli, Craig W Freyer, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Novel treatments for chronic lymphocytic leukemia and moving forwardJennifer R Brown, David L Porter, Susan M O'BrienBritish Journal of Haematology|December 16, 2016
The promise of chimeric antigen receptor T cells (CARTs) in leukaemiaRobert J Orlowski, David L Porter, Noelle V FreyJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 22, 2020
Tacrolimus induced pseudogout following allogeneic hematopoietic cell transplantDanielle A Cenin, Craig W Freyer, Colin B Ligon, et al.American Journal of Hematology|April 4, 2020
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agentsGee Youn Geeny Kim, Jonathan Burns, Craig W Freyer, et al.Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid LeukemiaMonica R Muppidi, Scott Portwood, Elizabeth A Griffiths, et al.Pageof 20